BIOGEN INC. Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax
BIOGEN INC. (BIIB) reported Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax of -$67.00 thousand for the 12-month period ending 2009-12-31, per its 10-K filed 2010-02-09.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax · last filed 2010-02-09
- BIOGEN INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2009 was -$67.00K.
- BIOGEN INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2008 was $0.00.
- BIOGEN INC. other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2007 was -$370.00K.
| Period end | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 12 month |
|---|---|
| 2009-12-31 | -$67.00K 10-K · filed 2010-02-09 |
| 2008-12-31 | $0.00 10-K · filed 2010-02-09 |
| 2007-12-31 | -$370.00K 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |